Anthony S. Marucci, PRESIDENT & CEO at Celldex Therapeutics, Inc. (CLDX), bought 11,500 shares at $26.82 ($308K) on 2024-11-11, disclosed to the SEC on 2024-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CLDX | BUY | 2015-08-14 | $97K | — | Filing → |
| CLDX | BUY | 2011-08-10 | $36K | — | Filing → |
| CLDX | BUY | 2010-09-13 | $41K | — | Filing → |